Journal of Applied Hematology

CASE REPORT
Year
: 2020  |  Volume : 11  |  Issue : 2  |  Page : 77--79

Valproic acid for the treatment of refractory pediatric primary bone anaplastic large-cell lymphoma: A case report and literature review


Randa I Al-Bloushy1, Salma H Sait1, Ali H Algiraigri2 
1 Department of Hematology, King Abdulaziz University Hospital, Jeddah, Saudi Arabia
2 Department of Hematology, King Abdulaziz University Hospital; King Faisal Special Hospital and Research Center, Jeddah, Saudi Arabia

Correspondence Address:
Dr. Ali H Algiraigri
Department of Hematology, King Abdulaziz University Hospital, Jeddah 22252
Saudi Arabia

Primary bony anaplastic large-cell lymphoma is quite rare in children but potentially life-threatening lymphoma. Such disease is challenging and often carries a poor prognosis. Here, we report a patient who presented with an aggressive bony lymphoma and failed to respond to conventional chemotherapy; however, he had a robust response to valproic acid, which changed his status from hopeless palliative case to a success story and allowed him to complete his intended chemotherapy protocol.


How to cite this article:
Al-Bloushy RI, Sait SH, Algiraigri AH. Valproic acid for the treatment of refractory pediatric primary bone anaplastic large-cell lymphoma: A case report and literature review.J Appl Hematol 2020;11:77-79


How to cite this URL:
Al-Bloushy RI, Sait SH, Algiraigri AH. Valproic acid for the treatment of refractory pediatric primary bone anaplastic large-cell lymphoma: A case report and literature review. J Appl Hematol [serial online] 2020 [cited 2021 Jan 19 ];11:77-79
Available from: https://www.jahjournal.org/article.asp?issn=1658-5127;year=2020;volume=11;issue=2;spage=77;epage=79;aulast=Al-Bloushy;type=0